RxMen: A Leading Men’s Health Tech Startup Raises Rs 5 Crore

RxMen has quickly established itself as a notable player in the men’s health tech sector, securing Rs 5 crore (approximately $570K) in its earliest funding round, spearheaded by Inflection Point Ventures (IPV). This funding round also included participation from SPA Family Ventures, Ankit Goel, Seven Square Ventures, and received a grant from Prosus Group.

Investment Strategy and Future Goals

The funding will be allocated for brand development, launching products under the RxMen name, and establishing co-branded clinics. The aim is to reach a positive EBITDA by October 2025.

Company Overview

Founded in 2023 by Shailja Mittal, RxMen is a comprehensive, clinic-led platform dedicated to men’s health. The startup prioritises root-cause treatments in areas such as sexual health, hormone balance, skin issues, stress management, and sleep quality.

Significant Growth Metrics

Over the past 20 months, RxMen has reportedly increased its revenue by 100 times and recently noted a Monthly Recurring Revenue (MRR) of $70,000 as of August 2025. The firm anticipates an Annual Recurring Revenue (ARR) of $1.7 million by FY26. RxMen has successfully completed more than 30,000 consultations and currently manages 6,000 consultations each month through a network of 30 specialists across urology, psychiatry, sexology, and therapy.

Innovative Developments

Additionally, RxMen has created a Sexual Health Index (SHI), which is undergoing validation at IIT Jodhpur. This index is constructed from insights gathered from 25,000 anonymised consultations and shows a 95% success rate based on SHI results.

Market Competition

RxMen is positioned to compete against other notable firms in the field, such as Man Matters (Mosaic Wellness), Bold Care, and Traya.